Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: A central pathway in progressive glomerulosclerosis

American Journal of Pathology

Volumn 161, Issue 6, 2002, Pages 2179-2193

  Abbate, Mauro ^a,c   Zoja, Carla ^a   Morigi, Marina ^a   Rottoli, Daniela ^a   Angioletti, Stefania ^a   Tomasoni, Susanna ^a   Zanchi, Cristina ^a   Longaretti, Lorena ^a   Donadelli, Roberta ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLASMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GLOMERULOSCLEROSIS; GLOMERULUS CAPILLARY; KIDNEY; KIDNEY DISEASE; KIDNEY TUMOR; MALE; MESANGIUM CELL; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 17644444238     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64495-1     Document Type: Article

References (71)

1. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307:652-659
2. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985, 76:612-619
3. Fries JWU, Sandstrom DJ, Meyer TW, Rennke HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989, 60:205-218
4. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990, 38: 384-394
5. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982, 22:112-126
6. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998, 339:1448-1456
7. Rennke HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 1994, 45:S58-S63
8. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 1998, 54:687-697
9. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS: Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999, 286:312-315
10. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein - Nephrin - Is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575-582
11. Somlo S, Mundel P: Getting a foothold in nephrotic syndrome. Nat Genet 2000, 24:333-335
12. Wickelgren I: First components found for new kidney filter. Science 1999, 286:225-226
13. Border WA, Noble NA, Jamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease Nature 1992, 360:361-364
14. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990, 86:453-462
15. Davies DJ, Messina A, Thumwood CM, Ryan GB: Glomerular podocyte injury in protein overload proteinuria. Pathology 1985, 17:412-419
16. Davies DJ, Brewer DB: Irreversible glomerular damage following heterologous serum albumin overload. J Pathol 1977, 123:45-52
17. Davies DJ, Brewer DB, Hardwicke J: Urinary proteins and glomerular morphometry in protein overload proteinuria Lab Invest 1978, 38: 232-243
18. Brewer DB, Filip O: The morphometry of the glomerular epithelial cell and its foot processes after the injection of bovine serum albumin or egg albumin. J Pathol 1976, 120:209-220
19. Marks MI, Drummond KN: Nephropathy and persistent proteinuria after albumin administration in the rat. Lab Invest 1970, 23:416-420
20. Stephenson LA, Haney LB, Hussaini IM, Karns LR, Glass II WF: Regulation of smooth muscle α-actin expression and hypertrophy in cultured mesangial cells. Kidney Int 1998, 54:1175-1187
21. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122:103-111
22. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993, 92:2597-2601
23. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993, 90:1814-1818
24. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-β isoforms in human glomerular diseases Kidney Int 1996, 49:461-469
25. Niemir ZI, Stein H, Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995, 48:1530-1541
26. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat J Clin Invest 1990, 85:541-549
27. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991, 39:1267-1273
28. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy J Nephrol 1993, 6:36-43
29. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 1996, 4:19-25
30. Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Benigni A: Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 1999, 10:1542-1549
31. Abbate M, Zoja C, Rottoli D, Corna D, Perico N, Bertani T, Remuzzi G: Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease. J Am Soc Nephrol 1999, 10:804-813
32. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971, 78:957-962
33. Read SM, Northcote DH: Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 1981, 116:53-64
34. Bonsnes RW, Tausski HA: The colorimetric determination of creatinine of the Jaffe reaction. J Biol Chem 1945, 158:581
35. 2-MRAP is modified by tissue processing. Eur J Cell Biol 1993, 61:139-149
36. McLean IW, Nakane PF: Periodate-lysine paraformaldehyde fixative: A new fixative for immunoelectron microscopy. J Histochem Cytochem 1974, 22:1077-1083
37. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992, 41:297-309
38. Zoja C, Liu XH, Donadelli R, Abbate M, Testa D, Corna D, Taraboletti G, Vecchi A, Dong QG, Rollins BJ, Bertani T, Remuzzi G: Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol 1997, 8:720-729
39. Mundel P, Reiser J, Borja AZM, Pavenstadt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines Exp Cell Res 1997, 236:248-258
40. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, Striker GE: Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 1988, 33:677-684
41. Johnson RJ, Ida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991, 87:847-858
42. Floege J, Johnson RJ, Gordon K, lida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991, 40:477-488
43. Zhang G, Moorhead PJ, El Nahas AM: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995, 3:308-318
44. Muchaneta-Kubara EC, El Nahas AM: Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997, 12:904-915
45. Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee K-W, Ziai F, Jiang T, Brenner BM, Mackenzie HS: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000, 58:1664-1676
46. Floege J, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, Couser WG: Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 1992, 67:486-497
47. Shimojo H: Adaptation and distortion of podocytes in rat remnant kidney. Pathol Int 1998, 48:368-383
48. Mundel P, Heid HW, Mundel TM, Kruger M, Reiser J, Kriz W: Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 1997, 139:193-204
49. Mundel P, Reiser J, Kriz W: Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 1997, 8: 697-705
50. Taal MW, Brenner BM: Renoprotective benefits of RAS inhibition: From ACEI to anglotensin II antagonists. Kidney Int 2000, 57:1803-1817
51. Ruggenenti P, Schieppati A, Remuzzi G: Progression, remission, regression of chronic renal diseases. Lancet 2001, 357:1601-1608
52. Nenov VD, Taal MW, Sakharova OV, Brenner BM: Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hyperten 2000, 9:85-97
53. Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I: Role for angiotensin II in an overt functional proteinuria. Kidney Int 1986, 30:538-545
54. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 1987, 61:531-538
55. Elema JD, Hoyer JR, Vernier RL: The glomerular mesangium: Uptake and transport of intravenously injected colloidal carbon in rats. Kidney Int 1976, 9:395-406
56. Stein HD, Feddergreen W, Kashgarian M, Sterzel RB: Role of angiotensin-II induced renal functional changes in mesangial deposition of exogenous ferritin in rats. Lab Invest 1983, 49:270-280
57. Barisoni L, Kriz W, Mundel P, D'Agati VD: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999, 10:51-61
58. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000, 58:173-181
59. Srivastava T, Garola RE, Whiting JM, Alon US: Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 2001, 59:118-125
60. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haring HU, Schleicher ED: AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells J Am Soc Nephrol 2000, 11:2007-2016
61. Inoki K, Haneda M, Ishida T, Mori H, Maeda S, Koya D, Sugimoto T, Kikkawa R: Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-β in mesangial cells. Kidney Int 2000, 58:S76-S80
62. Schiffer M, von Gersdorff G, Bitzer M, Susztak K, Bottinger EP: Smad proteins and transforming growth factor-β signaling. Kidney Int 2000, 58:S45-S52
63. Morigi M, Zoja C, Angioletti S, Zanchi C, Longaretti L, Donadelli R, Mundel P, Benigni A, Remuzzi G: Podocytes respond to protein overload by cytoskeleton rearrangement and upregulation of AP-1 dependent endothelin-1 (ET-1) gene expression. J Am Soc Nephrol 2001, 12:686A
64. Purkerson ML, Hoffsten PE, Klahr S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 1976, 9:407-417
65. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986, 77:1925-1930
66. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986, 77:1993-2000
67. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 2001, 12:941-948
68. Macconi D, Ghilardi M, Bonassi ME, Mohamed EI, Abbate M, Colombi F, Remuzzi G, Remuzzi A: Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 2000, 11:477-489
69. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994; 93:2431-2437
70. Riser BL, Ladson-Wofford S, Sharba A, Cortes P, Drake K, Guerin CJ, Yee J, Choi ME, Segarini PR, Narins RG:TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain. Kidney Int 1999 56:428-439
71. van Det NF, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR, van der Woude FJ: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 1997, 46:834-840